APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune System Allergy Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immune System Allergy Treatment Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchImmune System Allergy Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune System Allergy Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Immune System Allergy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune System Allergy Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune System Allergy Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Immune System Allergy Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Immune System Allergy Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immune System Allergy Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immune System Allergy Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immune System Allergy Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Immune System Allergy Treatment include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Immune System Allergy Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immune System Allergy Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune System Allergy Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune System Allergy Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune System Allergy Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immune System Allergy Treatment revenue, projected growth trends, production technology, application and end-user industry.

Immune System Allergy Treatment Segment by Company

Sanofi

Johnson and Johnson Services, Inc.

Pfizer Inc.

GlaxoSmithKline plc

Stallergenes Greer

LETIPharma

Dermapharm Holding

Allergy Therapeutics

Allergan plc

ALK-Abelló A/S

Immune System Allergy Treatment Segment by Type

Allergy Injection

Sublingual Immunotherapy

Immune System Allergy Treatment Segment by Application

Hospital

Clinic

Others

Immune System Allergy Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Immune System Allergy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Immune System Allergy Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune System Allergy Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune System Allergy Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Allergy Injection Major Player Table 3. Sublingual Immunotherapy Major Player Table 4. Global Immune System Allergy Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Immune System Allergy Treatment Industry Trends Table 9. Immune System Allergy Treatment Industry Drivers Table 10. Immune System Allergy Treatment Industry Opportunities and Challenges Table 11. Immune System Allergy Treatment Industry Restraints Table 12. Global Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Immune System Allergy Treatment Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Immune System Allergy Treatment Market Share by Region (2021-2026) Table 15. Global Immune System Allergy Treatment Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Immune System Allergy Treatment Market Share by Region (2027-2032) Table 17. Global Immune System Allergy Treatment Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Immune System Allergy Treatment Revenue Market Share by Players (2021-2026) Table 19. Global Immune System Allergy Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Immune System Allergy Treatment Key Players Headquarters & Area Served Table 21. Global Immune System Allergy Treatment Players, Product Type & Application Table 22. Global Immune System Allergy Treatment Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Immune System Allergy Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Immune System Allergy Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Immune System Allergy Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Immune System Allergy Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Immune System Allergy Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Immune System Allergy Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Immune System Allergy Treatment Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Immune System Allergy Treatment Product Portfolio Table 39. Sanofi Recent Development Table 40. Johnson and Johnson Services, Inc. Company Information Table 41. Johnson and Johnson Services, Inc. Business Overview Table 42. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio Table 44. Johnson and Johnson Services, Inc. Recent Development Table 45. Pfizer Inc. Company Information Table 46. Pfizer Inc. Business Overview Table 47. Pfizer Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Inc. Immune System Allergy Treatment Product Portfolio Table 49. Pfizer Inc. Recent Development Table 50. GlaxoSmithKline plc Company Information Table 51. GlaxoSmithKline plc Business Overview Table 52. GlaxoSmithKline plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio Table 54. GlaxoSmithKline plc Recent Development Table 55. Stallergenes Greer Company Information Table 56. Stallergenes Greer Business Overview Table 57. Stallergenes Greer Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Stallergenes Greer Immune System Allergy Treatment Product Portfolio Table 59. Stallergenes Greer Recent Development Table 60. LETIPharma Company Information Table 61. LETIPharma Business Overview Table 62. LETIPharma Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LETIPharma Immune System Allergy Treatment Product Portfolio Table 64. LETIPharma Recent Development Table 65. Dermapharm Holding Company Information Table 66. Dermapharm Holding Business Overview Table 67. Dermapharm Holding Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Dermapharm Holding Immune System Allergy Treatment Product Portfolio Table 69. Dermapharm Holding Recent Development Table 70. Allergy Therapeutics Company Information Table 71. Allergy Therapeutics Business Overview Table 72. Allergy Therapeutics Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Allergy Therapeutics Immune System Allergy Treatment Product Portfolio Table 74. Allergy Therapeutics Recent Development Table 75. Allergan plc Company Information Table 76. Allergan plc Business Overview Table 77. Allergan plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Allergan plc Immune System Allergy Treatment Product Portfolio Table 79. Allergan plc Recent Development Table 80. ALK-Abelló A/S Company Information Table 81. ALK-Abelló A/S Business Overview Table 82. ALK-Abelló A/S Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio Table 84. ALK-Abelló A/S Recent Development Table 85. North America Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Immune System Allergy Treatment Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Immune System Allergy Treatment Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Immune System Allergy Treatment Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Immune System Allergy Treatment Revenue by Country (US$ Million) & (2027-2032) Table 99. China Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 100. China Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 101. China Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 102. China Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Immune System Allergy Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Immune System Allergy Treatment Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Immune System Allergy Treatment Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Immune System Allergy Treatment Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Immune System Allergy Treatment Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Immune System Allergy Treatment Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Immune System Allergy Treatment Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Immune System Allergy Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Immune System Allergy Treatment Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Immune System Allergy Treatment Image Figure 2. Global Immune System Allergy Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune System Allergy Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Allergy Injection Image Figure 5. Sublingual Immunotherapy Image Figure 6. Global Immune System Allergy Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Immune System Allergy Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Immune System Allergy Treatment Market Size (US$ Million) & (2021-2032) Figure 12. Global Immune System Allergy Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Immune System Allergy Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Immune System Allergy Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Immune System Allergy Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Immune System Allergy Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Immune System Allergy Treatment Revenue Market Share by Type (2021-2032) Figure 19. Global Immune System Allergy Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Immune System Allergy Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Immune System Allergy Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Immune System Allergy Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Immune System Allergy Treatment Revenue Share by Type (2021-2032) Figure 24. North America Immune System Allergy Treatment Revenue Share by Application (2021-2032) Figure 25. North America Immune System Allergy Treatment Revenue Share by Country (2021-2032) Figure 26. United States Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Immune System Allergy Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Immune System Allergy Treatment Revenue Share by Type (2021-2032) Figure 31. Europe Immune System Allergy Treatment Revenue Share by Application (2021-2032) Figure 32. Europe Immune System Allergy Treatment Revenue Share by Country (2021-2032) Figure 33. Germany Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Immune System Allergy Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Immune System Allergy Treatment Revenue Share by Type (2021-2032) Figure 43. China Immune System Allergy Treatment Revenue Share by Application (2021-2032) Figure 44. Asia Immune System Allergy Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Immune System Allergy Treatment Revenue Share by Type (2021-2032) Figure 46. Asia Immune System Allergy Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Immune System Allergy Treatment Revenue Share by Region (2021-2032) Figure 48. Japan Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Immune System Allergy Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Immune System Allergy Treatment Revenue Share by Type (2021-2032) Figure 56. SAMEA Immune System Allergy Treatment Revenue Share by Application (2021-2032) Figure 57. SAMEA Immune System Allergy Treatment Revenue Share by Country (2021-2032) Figure 58. Brazil Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Immune System Allergy Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Allergy Injection
  • Sublingual Immunotherapy
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Stallergenes Greer
  • LETIPharma
  • Dermapharm Holding
  • Allergy Therapeutics
  • Allergan plc
  • ALK-Abelló A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immune System Allergy Treatment Market by Type
  3. 1.2.1 Global Immune System Allergy Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Allergy Injection
  5. 1.2.3 Sublingual Immunotherapy
  6. 1.3 Immune System Allergy Treatment Market by Application
  7. 1.3.1 Global Immune System Allergy Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Immune System Allergy Treatment Market Dynamics
  1. 2.1 Immune System Allergy Treatment Industry Trends
  2. 2.2 Immune System Allergy Treatment Industry Drivers
  3. 2.3 Immune System Allergy Treatment Industry Opportunities and Challenges
  4. 2.4 Immune System Allergy Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Immune System Allergy Treatment Market Perspective (2021-2032)
  2. 3.2 Global Immune System Allergy Treatment Growth Trends by Region
  3. 3.2.1 Global Immune System Allergy Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immune System Allergy Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Immune System Allergy Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Immune System Allergy Treatment Revenue by Players
  2. 4.1.1 Global Immune System Allergy Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Immune System Allergy Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Immune System Allergy Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immune System Allergy Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Immune System Allergy Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Immune System Allergy Treatment Players, Product Type & Application
  8. 4.5 Global Immune System Allergy Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Immune System Allergy Treatment Market CR5 and HHI
  11. 4.6.3 2025 Immune System Allergy Treatment Tier 1, Tier 2, and Tier 3
5 Immune System Allergy Treatment Market Size by Type
  1. 5.1 Global Immune System Allergy Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Immune System Allergy Treatment Revenue Market Share by Type (2021-2032)
6 Immune System Allergy Treatment Market Size by Application
  1. 6.1 Global Immune System Allergy Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Immune System Allergy Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Immune System Allergy Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Immune System Allergy Treatment Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson and Johnson Services, Inc.
  8. 7.2.1 Johnson and Johnson Services, Inc. Company Information
  9. 7.2.2 Johnson and Johnson Services, Inc. Business Overview
  10. 7.2.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio
  12. 7.2.5 Johnson and Johnson Services, Inc. Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Immune System Allergy Treatment Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 GlaxoSmithKline plc
  20. 7.4.1 GlaxoSmithKline plc Company Information
  21. 7.4.2 GlaxoSmithKline plc Business Overview
  22. 7.4.3 GlaxoSmithKline plc Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio
  24. 7.4.5 GlaxoSmithKline plc Recent Developments
  25. 7.5 Stallergenes Greer
  26. 7.5.1 Stallergenes Greer Company Information
  27. 7.5.2 Stallergenes Greer Business Overview
  28. 7.5.3 Stallergenes Greer Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Stallergenes Greer Immune System Allergy Treatment Product Portfolio
  30. 7.5.5 Stallergenes Greer Recent Developments
  31. 7.6 LETIPharma
  32. 7.6.1 LETIPharma Company Information
  33. 7.6.2 LETIPharma Business Overview
  34. 7.6.3 LETIPharma Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LETIPharma Immune System Allergy Treatment Product Portfolio
  36. 7.6.5 LETIPharma Recent Developments
  37. 7.7 Dermapharm Holding
  38. 7.7.1 Dermapharm Holding Company Information
  39. 7.7.2 Dermapharm Holding Business Overview
  40. 7.7.3 Dermapharm Holding Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Dermapharm Holding Immune System Allergy Treatment Product Portfolio
  42. 7.7.5 Dermapharm Holding Recent Developments
  43. 7.8 Allergy Therapeutics
  44. 7.8.1 Allergy Therapeutics Company Information
  45. 7.8.2 Allergy Therapeutics Business Overview
  46. 7.8.3 Allergy Therapeutics Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Allergy Therapeutics Immune System Allergy Treatment Product Portfolio
  48. 7.8.5 Allergy Therapeutics Recent Developments
  49. 7.9 Allergan plc
  50. 7.9.1 Allergan plc Company Information
  51. 7.9.2 Allergan plc Business Overview
  52. 7.9.3 Allergan plc Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Allergan plc Immune System Allergy Treatment Product Portfolio
  54. 7.9.5 Allergan plc Recent Developments
  55. 7.10 ALK-Abelló A/S
  56. 7.10.1 ALK-Abelló A/S Company Information
  57. 7.10.2 ALK-Abelló A/S Business Overview
  58. 7.10.3 ALK-Abelló A/S Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio
  60. 7.10.5 ALK-Abelló A/S Recent Developments
8 North America
  1. 8.1 North America Immune System Allergy Treatment Revenue (2021-2032)
  2. 8.2 North America Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Immune System Allergy Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Immune System Allergy Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Immune System Allergy Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Immune System Allergy Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Immune System Allergy Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Immune System Allergy Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Immune System Allergy Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Immune System Allergy Treatment Revenue by Country
  11. 8.6.1 North America Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Immune System Allergy Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Immune System Allergy Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Immune System Allergy Treatment Revenue (2021-2032)
  2. 9.2 Europe Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Immune System Allergy Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Immune System Allergy Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Immune System Allergy Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Immune System Allergy Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Immune System Allergy Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Immune System Allergy Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Immune System Allergy Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Immune System Allergy Treatment Revenue by Country
  11. 9.6.1 Europe Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Immune System Allergy Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Immune System Allergy Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Immune System Allergy Treatment Revenue (2021-2032)
  2. 10.2 China Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Immune System Allergy Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Immune System Allergy Treatment Revenue by Type (2027-2032)
  5. 10.3 China Immune System Allergy Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Immune System Allergy Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Immune System Allergy Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Immune System Allergy Treatment Revenue by Application (2027-2032)
  9. 10.5 China Immune System Allergy Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immune System Allergy Treatment Revenue (2021-2032)
  2. 11.2 Asia Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Immune System Allergy Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Immune System Allergy Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Immune System Allergy Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Immune System Allergy Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Immune System Allergy Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Immune System Allergy Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Immune System Allergy Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Immune System Allergy Treatment Revenue by Country
  11. 11.6.1 Asia Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Immune System Allergy Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Immune System Allergy Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immune System Allergy Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Immune System Allergy Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Immune System Allergy Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Immune System Allergy Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Immune System Allergy Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Immune System Allergy Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Immune System Allergy Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Immune System Allergy Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Immune System Allergy Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Immune System Allergy Treatment Revenue by Country
  11. 12.6.1 SAMEA Immune System Allergy Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Immune System Allergy Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Immune System Allergy Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst